Finally, we screened out nine target genes including TP53, CTNNB1, ARMC5, PRKAR1A, ZNRF3, RB1, APC, MEN1, and RPL22, and detected mutations of target genes in ACC tissues by FastTarget exons sequencing technology. This evidence concerns the gene MEN1 and adrenal cortex carcinoma.